Compare Stocks: TMCI vs. QTRX vs. CERS vs. PAVM
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
TMCIQTRXCERSPAVM
Market Snapshot
Current market context for the selected companies.
TMCI
$4.72
Market Cap
$312.82M
Sector
Healthcare
Industry
Medical Devices
Data through
2026-08-26
QTRX
$2.67
Market Cap
$131.95M
Sector
Healthcare
Industry
Medical Devices
Data through
2026-08-26
CERS
$2.75
Market Cap
$548.15M
Sector
Healthcare
Industry
Medical Devices
Data through
2026-08-26
PAVM
$5.42
Market Cap
$42.18M
Sector
Healthcare
Industry
Medical Devices
Data through
2026-08-26
Performance
Absolute returns and relative performance versus SPY.
| Metric | TMCI | QTRX | CERS | PAVM |
|---|---|---|---|---|
| 1 Month | +17.7% | -23.4% | -6.0% | +0.7% |
| 1 Month vs SPY | +14.4% | -26.7% | -9.3% | -2.6% |
| 3 Months | +62.8% | +0.9% | -2.7% | -14.0% |
| 3 Months vs SPY | +60.8% | -1.1% | -4.7% | -16.0% |
| 6 Months | +131.4% | -57.5% | +13.4% | -47.8% |
| 6 Months vs SPY | +120.9% | -67.9% | +3.0% | -58.2% |
| 1 Year | -36.8% | -42.7% | +114.5% | -63.1% |
| 1 Year vs SPY | -56.0% | -61.9% | +95.3% | -82.2% |
| 2 Years | -26.8% | -79.7% | +21.5% | -75.2% |
| 2 Years vs SPY | -63.4% | -116.2% | -15.1% | -111.8% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.